Nci 8511: Phase I/Ii Study Of Cetuximab With R04929097 In Colon Cancer

Nci 8511: Phase I/Ii Study Of Cetuximab With R04929097 In Colon Cancer

Sponsor(s)

H. Lee Moffitt Cancer Center and Research Institute

Principal Investigator(s)John Kauh, MD
Dates8/10/2010 - 8/05/2013